Effects of Rhodiola rosea on indomethacin-induced gastric injury

Year 2021, Volume: 48 Issue: 4, 732 - 739, 01.12.2021

Irmak Ferah Okkay Ufuk Okkay Ozhan Karatas

https://doi.org/10.5798/dicletip.1037590

Cited By: 4

Abstract

Effects of Rhodiola rosea on indomethacin-induced gastric injury

Abstract

Objective: The objective of the present study was to evaluate the effects of Rhodiola rosea in the indomethacin-induced ulcer model in rats and to clarify the underlying mechanisms of action.
Methods: Rats in treatment groups were treated with Rhodiola rosea (RR) 14 days. Peptic ulcer was induced by indomethacin (IND) injection (100 mg/kg, p.o.). The groups (n = 6) were designed as; Group I (control); Group II (IND): After 24h of food starvation, rats were given only 100 mg/kg IND by oral gavage to induce gastric mucosal injury. Group III (ESO): Rats were pretreated with 20 mg/kg of ESO for 14 consecutive days by oral gavage. Group IV (RR): Rats were pretreated with 500 mg/kg RR for 14 consecutive days with oral gavage.
Results: Rhodiola rosea effectively alleviated indomethacin-induced ulcer via reduction in oxidative stress (decreased MDA and increased SOD, and GSH). Moreover, Rhodiola rosea alleviated indomethacin-induced damage by regulating expressions of COX enzymes, prostaglandin E2, proliferating cell nuclear antigen (PCNA), cell proliferation, apoptosis and regulated the NF-κB signaling pathway. Rhodiola rosea also attenuated inflammatory injury by suppressing TNF-𝛼𝛼, IL-1β, and NF-κB. The caspase-3 expression was also down-regulated in stomach tissues.
Conclusions: In conclusion, Rhodiola rosea protected the gastric mucosa from harmful effects of indomethacin and as a natural medicinal herb, Rhodiola rosea might be a potential therapeutic agent for preventing and treating indomethacin-induced gastric damage.

Keywords

Rhodiola rosea, indomethacin, oxidative stress, inflammation, peptic ulcer.

References

• 1.Tytgat GN. Etiopathogenetic principles and pepticulcer disease classification. Dig Dis. 2011; 29: 454-8.
• 2.Xiao X, Nakatsu G, Jin Y, et al. Gut MicrobiotaMediates Protection Against Enteropathy Induced byIndomethacin. Sci Rep. 2017; 7: 40317.
• 3.McRorie JW, Kirby JA, Miner PB. Histamine2-receptor antagonists: Rapid development oftachyphylaxis with repeat dosing. World J GastrointestPharmacol Ther. 2014; 5: 57-62.